All prices are in US$ unless stated otherwise. See our Ordering
and Delivery FAQ for more information.
Conference Documentation: Pharmaceutical m-Health
SMI Publishing, Ltd - 10/11/2011 - ID: SMI3823231
| ||Publisher Purchase Options|
|Electronic Access - Single User Fulfilled By Publisher ||$800.00 || Add to cart |
|CD-ROM Mail Delivery ||$800.00 || Add to cart |
|Electronic Access - Global Site License Fulfilled By Publisher ||$2,400.00 || Add to cart |
Abstract | Table
Mi Presents their inaugural conference on...
About the conference
This conference will provide attendees with vital information on the current market and the opportunity to learn about mobile healthcare strategies from key industry players in this rapidly evolving field. In such an innovative and fast-paced sector, it is essential that you are kept up to date with the numerous ways the pharmaceutical industry can benefit from, and contribute to the increasing mobility of healthcare.
At this inaugural event, attendees will benefit from the unique opportunity to network with senior pharmaceutical executives from the leading organisations in the field as well as learning about a broad range of related issues in technological advancements and novel applications of pharmaceutical mobile healthcare.
The global telemedicine market is expected to grow from $9.8 billion in 2010 to $23 billion in 2015*, and therefore represents a major opportunity. The vast potential for mobile phones to change everyday life with their increasing technological capacity to connect people and systems over vast distances, send and receive larger amounts of information, and operate from ever more advanced platforms, affects people and businesses in a variety of ways. Healthcare is certainly no exception, and there are several areas of the pharmaceutical industry that are either undergoing fundamental changes to accommodate and gain from this mobility, or are about to.
Key Topics to be Addressed:
Marketing, Sales and CRM: With e-marketing a now long established faucet of promotion, the difference that a mobile personalised service can offer is significant. The opportunities for personalised information delivered through a variety of interactive mediums and devices are ever increasing. In addition, the options that open up to reps in the field as a result of mobile technology are vast, and therefore merit thorough discussion as featured at this event.
Healthcare professionals and communication: How can pharma gain from the fact that a growing percentage of physicians not only own smart phones, but use them regularly in the workplace? Through mobile e-detailing and e-prescribing apps for example, knowledge about products are more easily accessible, as is feedback on those products.
Anti counterfeiting and developing markets: The pharmaceutical industry looses billions a year from counterfeited goods, and the toll this takes on the health of the patients that use them is made all the more shocking by the fact that developing nations are the most vulnerable to this crime. The increasing usage of mobiles in such countries means that information on how to spot such goods can reach far and wide, as can healthcare information in general
Clinical trials: The possibilities to monitor patients from a distance via mobile connectivity are altering the way trials are conducted, as well as recruitment and retention. Self monitoring in chronic diseases has the potential to save an enormous amount each year.
Adherence: Improving patient adherence is of benefit to patients, healthcare professionals, and pharmaceutical companies themselves. The growing usage of mobile phones to issue medication reminders, and advise on the correct usage of pharmaceutical products, is therefore an exciting new outlet for improving adherence.
to View Enlarged